ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.

January 26, 2001

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

Troubled Allegheny Cuts Cancer Programs; Institution Holds Grants for NSABP, ECOG

July 10, 1998

Promotions at MSKCC: Fuks heads radiation oncology, Pfister named chief of Head & Neck Medical Oncology Service.

October 15, 2004

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014